Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It can't be ignored that yesterday's conference call had the opposite effect today that share holders were expecting. Reasons for that and or motives are speculative. Lets see..
At some point in the near future I would expect this to be updated reflecting inclusion of Aviptadil as part of the trial...thoughts?
https://clinicaltrials.gov/ct2/show/NCT04488081?term=i-spy&draw=2&rank=1
Yours? Or where did you find?
Inhaled trial to start January 10, per the latest.
https://clinicaltrials.gov/ct2/show/NCT04360096?term=aviptadil&draw=2&rank=3
I can only imagine the difficulties in the logistics of running trials at this time though. Hopefully they have been preparing and can roll out the trial quickly.
Why do you state EUA was denied? We have never seen that word used from the companies. Eua has not been granted based on data from September. Now that trial enrollment is complete, as per fda recommendation, data will be presented for re-review.
I read the PR from today differently. Simply stated the enrollment is closed, topping at 196. Whether they decide to present data to FDA on 165 or 196 is still a guess, if the later, then obviously next read from FDA will be in February sometime. PR also stated what we already knew, the EUA was NOT granted in September. So what we need to understand is the approach and timeline for presenting results, and what that means on the current process for FDA review.
I read the PR from today differently. Simply stated the enrollment is closed, topping at 196. Whether they decide to present data to FDA on 165 or 196 is still a guess, if the later, then obviously next read from FDA will be in February sometime. PR also stated what we already knew, the EUA was granted in September. So what we need to understand is the approach and timeline for presenting results, and what that means on the current process for FDA review.
this thing fought so hard from 9-24 to get to 0.70 today. then all traction lost in 10 minutes. i've been holding onto this roller coaster from early august. just too frustrating to watch this happen. companies should stop these risky videos and just use official PRs.
it was at that time that the share price began to drop.
https://fox4beaumont.com/news/baptist-hospitals-of-setx-conducts-study-that-could-help-covid-19-patients
At the 44 second-ish mark, the doctor states “vaso intestinal peptide”, VIP, RLF-100 is a VIP.
All we need is the peer review report, data on clinical trial, and Eua approval. Then we buy JJ a necktie and suit jacket, before he gets on tv again.
Where's the bottom on this one? and what are they going to do to turn this around...lot of damage done..can they even recover or they going to fold up shop...
company should have built on the momentum from last week by issuing a statement, updates, news, etc. this week. the silence is holding this back.
audio of interview notes R/S will be needed
ones are still available
Is there an approved RS currently for RNVA?
What caused the decline from April of this year?
What would be an example of share pricing targets for say 5 sell orders? Anyone care to share prospective?
Timeline not happening. Hemp is still illegal in TX. The doa cannot issue growing licenses until legislation is past. Chances of this happening before this years growing season, extremely slim.
News from yesterday should have not had this effect on SP.
What gives?
Do you know what name NOUV is licensed under in Canada for hemp:
https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/producing-selling-hemp/commercial-licence/list-approved-cultivars-cannabis-sativa.html
or for cannabis:
https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/industry-licensees-applicants/licensed-cultivators-processors-sellers.html
I don't see them listed for either.
Texas hemp growing and research still not legal. No state legislation has been passed allowing it or establishing procedures for license procurement. Any potential nouv has for being a hemp source, is months if not years away, therefore no revenue generated at this time whatsoever. Easy google searches will confirm.
CEO did not stay true to last PR indicating financials were coming that week, and to say the least, there have been no blow by blow updates since then.
I'm out of this one. GLTA.
Not to mention that hemp farming and research in texas is not moving:
[url][/url][tag]https://www.votehemp.com/states/texas-hemp-law/[/tag]
nor has real legislation in the state been introduced:
[url][/url][tag]https://www.brownsvilleherald.com/news/local/farm-bill-opens-door-to-hemp-as-commodity/article_638428ec-1238-11e9-8205-33ab41ff29bd.html[/tag]
it will be months if not years before anything grows in the greenhouses.
Dont think we've seen anything contradicting this:
https://www.apnews.com/ca7139016fda94ef9da8ddbb906ea384
ADTM-The beast awakes!
Level 2 anyone? Please post..
Some life today?
Where did you see that? Seems like a step in the right direction showing a bit of progress..
Can you point me to the small print (if it is something to read and not just an expression)..
I think I know what you are trying to say, but would like confirm.
Hi all, new to IHUB here, current ICNB share holder.
Does anyone know the following:
1. BEVMO http://www.bevmo.com/ doesn't show Belissima as available
2. http://christiebrinkley.com/ doesn't mention Belissima
3. Why this is still under construction http://iconicbrandsusa.com/
With all the recent news etc, it would seem like these three simple things could and shoulve been coordinated to paint a better picture.